Tema Oncology ETF (CANC)

NASDAQ: CANC · Real-Time Price · USD
23.45
-0.63 (-2.63%)
At close: Apr 1, 2025, 4:00 PM
23.33
-0.12 (-0.51%)
Pre-market: Apr 2, 2025, 4:09 AM EDT
-2.63%
Assets $65.19M
Expense Ratio 0.75%
PE Ratio 22.08
Shares Out 2.66M
Dividend (ttm) $0.73
Dividend Yield 3.11%
Ex-Dividend Date Dec 11, 2024
Payout Ratio 69.63%
1-Year Return -16.60%
Volume 2,333
Open 24.26
Previous Close 24.08
Day's Range 23.40 - 24.26
52-Week Low 23.40
52-Week High 30.11
Beta n/a
Holdings 53
Inception Date Aug 15, 2023

About CANC

Fund Home Page

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.

Asset Class Equity
Category Health
Stock Exchange NASDAQ
Ticker Symbol CANC
ETF Provider Tema

Top 10 Holdings

44.61% of assets
Name Symbol Weight
Revolution Medicines, Inc. RVMD 5.42%
Eli Lilly and Company LLY 5.31%
Roche Holding AG RHHBY 5.17%
Bristol-Myers Squibb Company BMY 4.54%
AstraZeneca PLC AZN 4.39%
Novartis AG NOVN 4.15%
BridgeBio Pharma, Inc. BBIO 4.15%
Exelixis, Inc. EXEL 4.03%
Nuvalent, Inc. NUVL 3.79%
Zai Lab Limited ZLAB 3.68%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 11, 2024 $0.72827 Dec 12, 2024
Dec 13, 2023 $0.14911 Dec 15, 2023
Full Dividend History

News

Tema Launches Two Innovative, Active ETF Thematic Strategies: Oncology & Global Royalties

NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”) launches two innovative and actively managed thematic ETF offerings: the Oncology ETF (CANC) and the Global Royalties ETF (ROYA). These strategies are the...

1 year ago - Business Wire